Verseau Therapeutics is Drug Discovery in United States that focus on inflammatory diseases business. Founded in 2017. They cover business area such as developer, macrophage checkpoint modulator, patient, cancer, immune and inflammatory disease, novel target, therapy, immune activator, silencer, physician.
2017
( 7 years old in 2024 )
Inflammatory Diseases
-
47 Wiggins Avenue
Bedford, MA 01730
United States
Private
developermacrophage checkpoint modulatorpatientcancerimmune and inflammatory diseasenovel targettherapyimmune activatorsilencerphysician
* We use standard office opening hours in near Verseau Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Verseau Therapeutics is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Verseau Therapeutics business is focusing on Inflammatory Diseases.
Verseau Therapeutics headquarter office and corporate office address is located in 47 Wiggins Avenue Bedford, MA 01730 United States.
Verseau Therapeutics was founded in United States.
In 2024, Verseau Therapeutics is currently focus on inflammatory diseases sector.
Above is snippet of Google Trends for "inflammatory diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Verseau Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
